TIMBLIZ Trademark
Trademark Overview
On Friday, October 17, 2025, a trademark application was filed for TIMBLIZ with the United States Patent and Trademark Office. The USPTO has given the TIMBLIZ trademark a serial number of 99448697. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 9, 2026. This trademark is owned by Auson Pharmaceuticals Inc.. The TIMBLIZ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical beta-blocker preparations; Pharmaceutical beta-blocker preparations in the form of a topical gel; Ophthalmic preparations containing timolol; Pharmaceutical preparations for the treatment of high blood pressure, glaucoma, and migraines; Pharmaceutical preparations for the treatment of elevated intraocular pressure in ocular hypertension or open angle glaucoma; Pharmaceutical preparations for the treatment of skin conditions, namely, infantile hemangiomas and chronic venous leg ulcers; Medicated cosmetics
General Information
| Serial Number | 99448697 |
| Word Mark | TIMBLIZ |
| Filing Date | Friday, October 17, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, June 9, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 9, 2026 |
Trademark Statements
| Translation of Words in Mark | The wording "TIMBLIZ" has no meaning in a foreign language. |
| Goods and Services | Pharmaceutical beta-blocker preparations; Pharmaceutical beta-blocker preparations in the form of a topical gel; Ophthalmic preparations containing timolol; Pharmaceutical preparations for the treatment of high blood pressure, glaucoma, and migraines; Pharmaceutical preparations for the treatment of elevated intraocular pressure in ocular hypertension or open angle glaucoma; Pharmaceutical preparations for the treatment of skin conditions, namely, infantile hemangiomas and chronic venous leg ulcers; Medicated cosmetics |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 17, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Auson Pharmaceuticals Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Bridgewater, NJ 08807
US |
| Party Name | Auson Pharmaceuticals Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Bridgewater, NJ 08807
US |
Trademark Events
| Event Date | Event Description |
| Friday, October 17, 2025 | NEW APPLICATION ENTERED |
| Friday, October 17, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, March 3, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 5, 2026 | ASSIGNED TO EXAMINER |
| Thursday, March 5, 2026 | NON-FINAL ACTION WRITTEN |
| Thursday, March 5, 2026 | NON-FINAL ACTION E-MAILED |
| Thursday, March 5, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, May 11, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 11, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 12, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 12, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 3, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 9, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 9, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
